In addition, a SNP (rs6721961) in the promoter region of Nrf2 (Nrf2 regulatory SNP-617) was reported to be involved in carcinogenesis [7, 8], and is associated with a significantly higher risk of developing non-small cell lung cancer [10]. Here, NFE2L2 is linked to non-small cell lung carcinoma.